17β-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: A correlation to clinicopathological parameters

British Journal of Cancer

Volumn 82, Issue 3, 2000, Pages 518-523

  Suzuki, T ^a   Moriya, T ^b   Ariga, N ^b   Kaneko, C ^b   Kanazawa, M ^b   Sasano, H ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

17 HSD; Breast; Carcinoma; Human; Immunohistochemistry; Oestrogen

Indexed keywords

ESTROGEN RECEPTOR; TESTOSTERONE 17BETA DEHYDROGENASE; 3 (OR 17) BETA HYDROXYSTEROID DEHYDROGENASE; 3 (OR 17)-BETA-HYDROXYSTEROID DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASE; ISOENZYME; KI 67 ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; BREAST TUMOR; ENZYMOLOGY; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

17-HYDROXYSTEROID DEHYDROGENASES; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KI-67 ANTIGEN; MIDDLE AGED; PROGNOSIS;

EID: 0034132569     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0956     Document Type: Article

References (36)

1. Adams EF, Goldham NG and James VTH (1988) Steroidal regulation of oestradiol-17β dehydrogenase activity of the human breast cancer cell line MCF-7. J Endocrinol 118 149-154
2. Bloom HJG and Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11 359-377
3. Bonney RC, Reed MJ, Davison K, Beraneck PA and James VTH (1983) The relationship between 17β-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clin Endocrinol 19 727-739
4. Brown DC and Gatter KC (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17 489-503
5. Bulun SE and Simpson ER (1994) Regulation of aromatase expression in human tissues. Breast Cancer Res Treat 30 530-535
6. Casey ML, MacDonal PC and Andersson S (1994) 17β-hydroxysteroid dehydrogenase type 2* chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest 94 2135-2141
7. Elston CW and Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19 403-410
8. Fournier S, Brihmat F, Sterkers N, Martin PM, Kutten F and Mauvais-Jarvis P (1985) Estradiol 17β-hydroxysteroid dehydrogenase, a marker of breast hormone dependency. Cancer Res 45 2895-2899
9. Gast MJ, Sims HF, Murdock GL, Gast PM and Strauss AW (1989) Isolation and sequencing of a cDNA clone encoding human placental 17β-estradiol dehydrogenase: identification of the putative cofactor binding site. Am J Obstet Gynecol 161 1726-1731
10. Gerdes J, Schwab U, Lemke H and Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31 13-20
11. James VHT, Reed MJ and Folkerd EJ (1981) Studies of estrogen metabolism in postmenopausal women with cancer. J Steroid Biochem 15 235-246
12. Leszczynski D, Santner SJ, Feil PD and Santen RJ (1988) β-hydroxysteroid dehydrogenase in human breast cancer analysis of kinetic and clinical parameters. Steroids 51 299-316
13. Luu-The V, Labrie C, Zhao HF, Couet J, Lachance Y, Simard J, Leblanc G, Cote J, Berube D, Gagne R and Labrie F (1989) Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′ termini in human placenta. Mol Endocrinol 3 1301-1309
14. Marrazzo A, La Bara G, Taormina P and Bazan P (1989) Determination of oestrogen receptors with monoclonal antibodies in fine needle aspirates of breast carcinoma. Br J Cancer 59 426-428
15. Miettinen MM, Mustonen MVJ, Poutanen MH, Isomaa VV and Vihko RK (1996) Human 17β-hydroxysteroid dehydrogenase type 1 and type 2 isozymes have opposite activities in cultured cells and characteristic cell-and tissue-specific expression. Biochem J 314 839-845
16. Miller WR (1991) Aromatase activity in breast tissue. J Steroid Biochem Mol Biol 39 783-790
17. Miller WR, Hawkins RA and Forrest AM (1982) Significance of aromatase activity in human breast cancer. Cancer Res 42 3365-3368
18. Moghrabi N, Head JR and Andersson S (1997) Cell type-specific expression of 17β-hydroxysteroid dehydrogenase type 2 in human placenta and fetal liver. J Clin Endocrinol Metab 82 3872-3878
19. Peltoketo H, Isomaa V, Maentausta O and Vihko R (1988) Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett 239 73-77
20. Pollow K, Boquoi E, Baumann J, Schmidt-Gollwitzer M and Pollow B (1977) Comparison of the in vitro conversion of estradiol-17β to estrone of normal and neoplastic human breast tissue. Mol Cell Endocrinol 6 333-348
21. Poutanen M, Isomaa V, Kainulainen K and Vihko R (1990) Progestin induction of 17β-hydroxysteroid dehydrogenase enzyme protein in the T-47D human breast-cancer cell line. Int J Cancer 46 897-901
22. Poutanen M, Isomaa V, Lehto VP and Vihko R (1992a) Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer 50 386-390
23. Poutanen M, Moncharmont B and Vihko R (1992b) 17β-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin. Cancer Res 52 290-294
24. Reiner A, Reiner G, Spona J, Schemper M and Holzner JH (1988) Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. Cancer 61 1149-1154
25. Rose C, Thorpe SM, Mouridsen HT, Andersen JA, Brincker H and Andersen KW (1983) Anti-oestrogen retreatment of post menopausal women with primary high risk breast cancer. Br Cancer Res Treat 3 77-84
26. Rosen PP (1996) Rosen's Breast Pathology. Lippincott-Raven: Philadelphia
27. Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Bulun SE, Silverberg SG and Nagura H (1996) Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab 81 4042-4046
28. Sasano H, Nagura H, Harada N, Goukon Y and Kimura M (1994) Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25 530-535
29. Suzuki T, Sasano H, Kimura N, Tamura M, Fukaya T, Yajima A and Nagura H (1994) Immunohistohemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Hum Reprod 9 1589-1595
30. Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A and Nagura H (1998) Cyclic changes of vasculature and vascular phenotypes in normal human ovaries. Hum Reprod 13 953-959
31. Takeyama J, Sasano H, Suzuki T, Iinuma K, Nagura H and Andersson S (1998) 17β-hydroxysteroid dehydrogenase type 1 and 2 in human placenta: an immunohistochemical study with correlation to placental development. J Clin Endocrinol Metab 83 3710-3715
32. Thomas DB (1984) Do hormones cause cancer? Cancer 53 595-604
33. Veronese SM and Gambacorta M (1991) Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic features. Am J Clin Pathol 95 30-34
34. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M and Lampertico P (1993) Proliferation index as a prognostic marker in breast cancer. Cancer 71 3926-3931
35. Vihko R and Apter D (1989) Endogenous steroids in the pathophysiology of breast cancer. CRC Crit Rev Oncol/Hematol 9 1-16
36. Wu L, Einstein M, Geissler WM, Chan HK, Ellison KO and Anderen S (1993) Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem 168 12964-12969